Profile: MaxCyte, Inc. provides clinical/commercial cell modification technologies and unparalleled expertise to the life sciences community. Our transfection technology platform enables the discovery, development, manufacturing and delivery of important therapeutic products for a wide range of diseases. We provide critical enablement for cell therapeutics targeting a broad range of chronic diseases by allowing the controlled modification of cell function. We offer STX scalable transfection system expressly for rapid, scalable & reagent-free transfection for small molecule drug discovery using cell based assays for high throughput and high content screening, preclinical protein production & other cell based applications.